Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,771 | 186 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,215 | 92 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $429.40 | 28 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $341.34 | 18 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $161.03 | 13 | $0 (2023) |
| Daiichi Sankyo Inc. | $137.98 | 6 | $0 (2023) |
| UCB, Inc. | $101.82 | 7 | $0 (2020) |
| AIMMUNE THERAPEUTICS, INC. | $58.80 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $46.91 | 3 | $0 (2023) |
| Pacira Pharmaceuticals Incorporated | $44.93 | 2 | $0 (2018) |
| Braintree Laboratories, Inc. | $41.90 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $393.88 | 28 | ABBVIE INC. ($208.37) |
| 2023 | $482.35 | 31 | Takeda Pharmaceuticals U.S.A., Inc. ($157.34) |
| 2022 | $909.43 | 62 | ABBVIE INC. ($309.64) |
| 2021 | $271.63 | 19 | AbbVie Inc. ($162.62) |
| 2020 | $219.98 | 13 | AbbVie Inc. ($163.75) |
| 2019 | $391.42 | 27 | AbbVie, Inc. ($291.77) |
| 2018 | $76.57 | 4 | Pacira Pharmaceuticals Incorporated ($44.93) |
| 2017 | $25.52 | 2 | UCB, Inc. ($25.52) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Rare Disease | ||||||
| 10/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Immunology | ||||||
| 09/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Gastroenterology | ||||||
| 04/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.30 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/20/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/04/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.30 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 492 | 494 | $231,975 | $44,987 |
| 2022 | 3 | 558 | 560 | $375,600 | $53,814 |
| 2021 | 3 | 673 | 681 | $518,250 | $65,590 |
| 2020 | 3 | 674 | 681 | $647,475 | $66,984 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00812 | Anesthesia for exam of colon using an endoscope | Office | 2023 | 291 | 291 | $138,225 | $26,769 | 19.4% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2023 | 119 | 121 | $54,675 | $11,257 | 20.6% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2023 | 82 | 82 | $39,075 | $6,962 | 17.8% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2022 | 229 | 230 | $165,900 | $21,898 | 13.2% |
| 00812 | Anesthesia for exam of colon using an endoscope | Office | 2022 | 175 | 175 | $103,875 | $16,233 | 15.6% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2022 | 154 | 155 | $105,825 | $15,683 | 14.8% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2021 | 341 | 342 | $258,675 | $32,555 | 12.6% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 200 | 207 | $163,500 | $20,763 | 12.7% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Office | 2021 | 132 | 132 | $96,075 | $12,272 | 12.8% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2020 | 345 | 347 | $306,550 | $33,771 | 11.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 204 | 209 | $231,525 | $21,363 | 9.2% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Office | 2020 | 125 | 125 | $109,400 | $11,849 | 10.8% |
About Dr. Stephen Scharf, M.D
Dr. Stephen Scharf, M.D is a Anesthesiology healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629073671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Scharf, M.D has received a total of $2,771 in payments from pharmaceutical and medical device companies, with $393.88 received in 2024. These payments were reported across 186 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,771).
As a Medicare-enrolled provider, Scharf has provided services to 2,397 Medicare beneficiaries, totaling 2,416 services with total Medicare billing of $231,375. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Lynchburg, VA
- Active Since 06/16/2005
- Last Updated 08/08/2007
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1629073671
Products in Payments
- ENTYVIO (Biological) $398.77
- HUMIRA (Biological) $355.36
- XIFAXAN (Drug) $297.26
- Humira (Biological) $252.89
- ZENPEP (Drug) $219.83
- RINVOQ (Biological) $196.35
- SKYRIZI (Biological) $164.68
- INJECTAFER (Drug) $137.98
- LINZESS (Drug) $137.81
- Cimzia (Drug) $101.82
- CREON (Drug) $60.54
- EXPAREL (Drug) $44.93
- Creon (Drug) $38.88
- DIFICID (Drug) $32.19
- IBSRELA (Drug) $30.89
- TREMFYA (Drug) $27.53
- SUTAB (Drug) $26.60
- DUPIXENT (Biological) $19.81
- IQIRVO (Drug) $19.73
- AVSOLA (Biological) $19.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Lynchburg
Dr. Ruzbeh Toussi, D.o, D.O
Anesthesiology — Payments: $10,756
Reza Salajegheh, M.d, M.D
Anesthesiology — Payments: $4,372
Dr. Karen Burnham, Md Dabpm Daapm, MD DABPM DAAPM
Anesthesiology — Payments: $2,564
Linda Fields, M.d, M.D
Anesthesiology — Payments: $2,380
Dr. Jennifer Charlton, Md, MD
Anesthesiology — Payments: $2,362
Terry Hurt, M.d, M.D
Anesthesiology — Payments: $2,290